| Basics |
Stryker Corporation
Stryker Corp is engaged in designing, manufacturing and marketing of medical equipment, instruments, and implantable devices. Its products include hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, and spinal devices.
|
| IPO Date: |
January 2, 1990 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$135.41B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.27 | 0.94%
|
| Avg Daily Range (30 D): |
$3.63 | 1.00%
|
| Avg Daily Range (90 D): |
$3.19 | 0.86%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.42M |
| Avg Daily Volume (30 D): |
1.38M |
| Avg Daily Volume (90 D): |
1.12M |
| Trade Size |
| Avg Trade Size (Sh.): |
97 |
| Avg Trade Size (Sh.) (30 D): |
29 |
| Avg Trade Size (Sh.) (90 D): |
31 |
| Institutional Trades |
| Total Inst.Trades: |
31,333 |
| Avg Inst. Trade: |
$6.94M |
| Avg Inst. Trade (30 D): |
$30.17M |
| Avg Inst. Trade (90 D): |
$32.41M |
| Avg Inst. Trade Volume: |
.05M |
| Avg Inst. Trades (Per Day): |
5 |
| Market Closing Trades |
| Avg Closing Trade: |
$28.85M |
| Avg Closing Trade (30 D): |
$99.76M |
| Avg Closing Trade (90 D): |
$95.91M |
| Avg Closing Volume: |
147.62K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
|
$2.25
|
$2.32
|
|
Diluted EPS
|
|
$2.22
|
$2.29
|
|
Revenue
|
$
|
$ 6.06B
|
$ 6.02B
|
|
Gross Profit
|
$
|
$ 3.85B
|
$ 3.84B
|
|
Net Income / Loss
|
$
|
$ 859M
|
$ 884M
|
|
Operating Income / Loss
|
$
|
$ 1.14B
|
$ 1.11B
|
|
Cost of Revenue
|
$
|
$ 2.21B
|
$ 2.18B
|
|
Net Cash Flow
|
$
|
$ 881M
|
$ 55M
|
|
PE Ratio
|
|
|
|
| Splits |
|
May 17, 2004:
2:1
|
|
May 15, 2000:
2:1
|
|
|
|
